Programme details

EU leaders are becoming increasingly concerned about the rise in rates of infection. The virus disease is spreading more and more outside the high risk groups
The research laboratory in Rixensart in Belgium searches for new ways to halt the pandemic
Virologist Gerald Voss is coordinating a team of genetic engineers from Belgium, France and the United Kingdom. Their aim is to develop a vaccine against HIV. In the developed world, so-called antiretroviral treatments have reduced both the mortality and the morbidity of HIV infection. But the aim of the team is to create a vaccine, not to relieve symptoms, but to stop the virus entirely.